InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the complete record of transactions filed by Nichol Carrie Ann, Officier. Officer active across 2 companies, notably Zimmer Biomet Holdings, INC.. Aggregated, 4 reports have been published. History available since 1 October 2021. The latest transaction was disclosed on 3 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Nichol Carrie Ann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
5,367 股@ US$69.61100.0% 占其流量Common StockSEC:0001225208-26-003140:0
7,569 股0Common StockSEC:0001225208-26-001982:0
32,333 股0Common StockSEC:0001225208-25-002837:0
164 股0Common StockSEC:0001062993-21-009219:0
4 条申报中的 4 条
About Nichol Carrie Ann
Carrie Ann Nichol is Vice President, Controller & CAO of Zimmer Biomet Holdings, Inc. In this role, she oversees the financial and control operations of the company. Zimmer Biomet is a leader in the medical devices field. Carrie plays a key role in financial management and compliance.
